GDUFA Research Outcomes
MR Oral Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to modified release generic drug products.
-
Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release from Nifedipine Extended-Release Tablets
Gao, Zongming; Ngo, Cindy; Ye, Wei; Rodriguez, Jason; Keire, David; Sun, Dajun; Wen, Hong; Jiang, Wenlei
-
Nifedipine Release From Extended-Release Solid Oral Formulations Using In Vitro Dissolution Testing Under Simulated Gastrointestinal Compression
Gao, Zongming; Tian, Li; Rodriguez, Jason
-
Quantitative Methods and Modeling to Evaluate Alternative Approaches for COVID-19 Interrupted Bioequivalence Studies
Zhao, Liang
-
FEV1 Based Bioequivalence Study for Inhaled Corticosteroids
Zhao, Liang
-
Use of Modeling and Simulation to Support New BE Approaches
Zhao, Liang
-
Beyond General Guidance: Tailored PSG Recommendations for Immediate Release Drug Products
Zhang, Qi
-
Intestinal Influx Transporters: A Missing Piece in the Puzzle?
Zhang, Lei
-
Totality of Evidence Including PBPK Modeling to Support BE Assessment and Approval of Mesalamine Delayed Release Tablets (Part II)
Wu, Fang
-
PBPK Absorption Modeling to Support Risk Assessment and Biowaiver for Generic Oral Products
Wu, Fang
-
Bioequivalence Approaches for Long-Acting Drug Products: Regulatory and Scientific Considerations
Wang, Yan